Reducing Prostate Cancer Overdiagnosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. Rural-urban disparities in prostate-specific antigen testing and shared decision-making in the US.Cancer causes & control : CCC · 2026
   Article
2. Overdiagnosis of Papillary Thyroid Cancer.JAMA network open · 2026
   Article
3. Trends in the Hidden Burden of Cancer in an Autopsy-Based Study Over 66 Years in Japan.JAMA network open · 2026
   Article
4. PRE-POET: a qualitative interview-based study to explore patient-relevant factors in the context of prostate biopsy.BMC urology · 2025
   Article
5. A strategy to reduce unnecessary prostate biopsies in patients with tPSA >10 ng ml -1 and PI-RADS 1-3.Asian journal of andrology · 2025
   Article
6. Overdiagnosis and Overtreatment in Prostate Cancer.Diseases (Basel, Switzerland) · 2025
   Review
7. Three-dimensional spatial localization and volume estimation of prostate tumors usingEuropean journal of nuclear medicine and molecular imaging · 2025
   Article
8. Machine learning based androgen receptor regulatory gene-related random forest survival model for precise treatment decision in prostate cancer.Heliyon · 2024
   Article
9. Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis.Annals of internal medicine · 2024
   Article
10. Creating a novel multiparametric magnetic resonance imaging-based biopsy strategy for reducing unnecessary prostate biopsies: a retrospective cohort study.Quantitative imaging in medicine and surgery · 2024
    Article
11. Protocol for SNOTOB study: radical prostatectomy without prostate biopsy followingBMJ open · 2023
    Article
12. Multiplexed electrochemical assays for clinical applications.Current opinion in electrochemistry · 2023
    Article
13. A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer.Cancers · 2023
    Article

Corrections and comments

• Comment on
  Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only.2022

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as